Skip to main content

Table 1 Pooled relative risks of CVDs and all-cause mortality by blood TG levels

From: Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies

  N Overall effects I 2 P for heterogeneity Begg’s test Influence analyses
RR (95% CIs) P (%) (P value) Minimum Maximum
Cardiovascular disease mortality
TG groups, mg/dl
  <90 10 0.83 (0.75, 0.93) 0.001 21.6 0.244 0.592 0.80 (0.71, 0.91) 0.85 (0.76, 0.94)
  90-150 12 1.00 (referent)       
  150-200 12 1.15 (1.03, 1.29) 0.015 22.5 0.222 0.150 1.12 (1.00, 1.27) 1.19 (1.08, 1.32)
  >200 8 1.25 (1.05, 1.50) 0.013 66.2 0.004 0.711 1.22 (1.00, 1.49) 1.33 (1.13, 1.57)
Per 1 mmol/L TG 22 1.13 (1.07, 1.19) 0.000 65.9 0.000 1.000 1.11 (1.06, 1.17) 1.14 (1.08, 1.20)
Per 1ln (mmol/L TG) 9 1.16 (1.05, 1.29) 0.004 32.3 0.160 0.754 1.06 (1.02,1.11) 1.24 (1.11, 1.39)
All-cause mortality
TG groups, mg/dl         
  <90 12 0.94 (0.85, 1.03) 0.150 71.1 0.000 0.732 0.90 (0.83, 0.97) 0.96 (0.84, 1.06)
  90-150 14 1.00 (referent)       
  150-200 14 1.09 (1.02, 1.17) 0.011 33.3 0.108 1.000 1.08 (1.00, 1.16) 1.11 (1.04, 1.19)
 00A0 > 200 8 1.20 (1.04, 1.38) 0.011 75.4 0.000 0.711 1.17 (1.01, 1.35) 1.25 (1.14, 1.37)
Per 1 mmol/L TG 22 1.12 (1.07, 1.16) 0.000 75.9 0.000 0.866 1.11 (1.07, 1.15) 1.13 (1.08, 1.18)
Per 1 ln (mmol/L TG) 8 1.11 (1.01, 1.23) 0.030 62.4 0.010 0.711 1.08 (0.99, 1.18) 1.14 (1.02, 1.28)
  1. † Random-effects model.
  2. RR, relative risk; CI, confidence interval; TG: triglycerides; CVDs: cardiovascular diseases.